Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes. (Q53631060)

16 May 2018

title

Transactivation of the epidermal growth factor receptor by angiotensin II in glomerular podocytes. (English)

1 reference

16 May 2018

author name string

Patrick J Flannery

series ordinal

1

1 reference

16 May 2018

Robert F Spurney

series ordinal

2

1 reference

16 May 2018

publication date

22 March 2006

1 reference

16 May 2018

published in

The Nephron Journals

1 reference

16 May 2018

volume

103

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

e109-18

1 reference

16 May 2018

Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis

cites work

1 reference

Nomenclature for angiotensin receptors. A report of the Nomenclature Committee of the Council for High Blood Pressure Research.

21 January 2018

1 reference

Signal transduction from the angiotensin II AT2 receptor

21 January 2018

1 reference

Identification of angiotensin II receptor subtypes

21 January 2018

1 reference

Characterization of angiotensin II-receptor subtypes in podocytes

21 January 2018

1 reference

Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells

21 January 2018

1 reference

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

21 January 2018

1 reference

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

21 January 2018

1 reference

Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data

21 January 2018

1 reference

Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells

21 January 2018

1 reference

Adenoviral-directed expression of the type 1A angiotensin receptor promotes cardiomyocyte hypertrophy via transactivation of the epidermal growth factor receptor

21 January 2018

1 reference

Increased angiotensin II-mediated Src signaling via epidermal growth factor receptor transactivation is associated with decreased C-terminal Src kinase activity in vascular smooth muscle cells from spontaneously hypertensive rats

21 January 2018

1 reference

Angiotensin II-induced cardiac hypertrophy and hypertension are attenuated by epidermal growth factor receptor antisense.

21 January 2018

1 reference

Metalloprotease inhibitor blocks angiotensin II-induced migration through inhibition of epidermal growth factor receptor transactivation

21 January 2018

1 reference

Phosphorylation of the type 1A angiotensin II receptor by G protein-coupled receptor kinases and protein kinase C

21 January 2018

1 reference

beta-arrestin-dependent endocytosis of proteinase-activated receptor 2 is required for intracellular targeting of activated ERK1/2

21 January 2018

1 reference

Role of C-terminal serines in desensitization and phosphorylation of the mouse thromboxane receptor

21 January 2018

1 reference

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

Role of HER receptors family in development and differentiation.

21 January 2018

1 reference

Role of EGFR transactivation in angiotensin II signaling to extracellular regulated kinase in preglomerular smooth muscle cells

21 January 2018

1 reference

TGF-beta signaling and the fibrotic response

21 January 2018

1 reference

High glucose induced VEGF expression via PKC and ERK in glomerular podocytes

21 January 2018

1 reference

Characterization of the angiotensin II AT1 receptor subtype involved in DNA synthesis in cultured vascular smooth muscle cells

21 January 2018

1 reference

The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer

21 January 2018

1 reference

Process formation of the renal glomerular podocyte: is there common molecular machinery for processes of podocytes and neurons?

21 January 2018

1 reference

Mechanism of the process formation; podocytes vs. neurons

21 January 2018

1 reference

Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes

21 January 2018

1 reference

The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death

21 January 2018

1 reference

Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP.

21 January 2018

1 reference

Angiotensin-converting enzyme inhibition but not angiotensin II receptor blockade regulates matrix metalloproteinase activity in patients with glomerulonephritis

21 January 2018

1 reference

Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases

21 January 2018

1 reference

AT1 receptor mutant lacking heterotrimeric G protein coupling activates the Src-Ras-ERK pathway without nuclear translocation of ERKs.

21 January 2018

1 reference

Requirement of Ca(2+) and PKCdelta for Janus kinase 2 activation by angiotensin II: involvement of PYK2

21 January 2018

1 reference

Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity

21 January 2018

1 reference

Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck.

21 January 2018

1 reference

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000092196

1 reference

16 May 2018

1 reference

16 May 2018